Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA’s Von Eschenbach Returns To Texas In January; Will He Also Return To MD Anderson?

This article was originally published in The Pink Sheet Daily

Executive Summary

Von Eschenbach’s resignation is effective Jan. 20; FDA commissioner expresses hope that senior team will remain at least partly intact.
Advertisement

Related Content

Von Eschenbach’s post-FDA plans
Von Eschenbach’s post-FDA plans
FDA’s Interim Commissioner: Manager or Scientist?
FDA’s Interim Commissioner: Manager or Scientist?
No FDAer For Commissioner, Interim or Otherwise, Rep. Stupak Urges Obama
Who Will Run FDA Under Obama?
FDA’s First Chief Scientist Is Wake Forest Oncologist Frank Torti
FDA's Schwetz Is Acting Commissioner: RU-486 Appears To Be Touchstone
FDA's Schwetz Is Acting Commissioner: RU-486 Appears To Be Touchstone

Topics

Advertisement
UsernamePublicRestriction

Register

PS067128

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel